First-Line Dual Immunotherapy, a Treatment Option in First-Line Metastatic Non-Small-Cell Lung Cancer: Are We Ready to Use It?
Détails
ID Serval
serval:BIB_FCBB794FB641
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
First-Line Dual Immunotherapy, a Treatment Option in First-Line Metastatic Non-Small-Cell Lung Cancer: Are We Ready to Use It?
Périodique
Journal of clinical oncology
ISSN
1527-7755 (Electronic)
ISSN-L
0732-183X
Statut éditorial
Publié
Date de publication
01/02/2024
Peer-reviewed
Oui
Volume
42
Numéro
4
Pages
378-382
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Publication Status: ppublish
Résumé
This article provides valuable insights into the use of dual immunotherapy for patients with metastatic NSCLC.
Mots-clé
Humans, Carcinoma, Non-Small-Cell Lung/drug therapy, Carcinoma, Non-Small-Cell Lung/pathology, Lung Neoplasms/drug therapy, Lung Neoplasms/pathology, Immunotherapy
Pubmed
Web of science
Création de la notice
04/12/2023 14:22
Dernière modification de la notice
22/06/2024 6:07
Données d'usage
